Advances in Anti-Rheumatic Therapy
Kim D. Rainsford(Editor)
CRC Press
1st Edition
Published on 3. February 2022
Book
Paperback/Softback
240 pages
978-0-367-24689-1 (ISBN)
Description
First published in 1996: This work on advances in anti-rheumatic therapy covers topics such as: outcome measures in clinical trials of anti-rheumatic drugs; azapropazone (AZP); the mode of action of glucocorticoids; and clinical trials of oral chondroitin sulphate in the treatment of osteoarthritis.
More details
Series
Language
English
Place of publication
London
United Kingdom
Publishing group
Taylor & Francis Ltd
Target group
Professional and scholarly
Professional
Illustrations
54 s/w Tabellen
54 Tables, black and white
Dimensions
Height: 254 mm
Width: 178 mm
ISBN-13
978-0-367-24689-1 (9780367246891)
Copyright in bibliographic data is held by Nielsen Book Services Limited or its licensors: all rights reserved.
Schweitzer Classification
Persons
K.D. Rainsford is Professor and Head, Division of Biomedical Sciences, School of Science, Sheffield Hallam University, Sheffield, England.
Editor
Sheffield, Hallam University, Sheffield, UK
Contributions
Albany Medical College, New York, USA
McMaster University, Hamilton, Ontario, Canada
Content
1. Introduction to Advances in Anti-Rheumatic Therapy 2. Outcome Measures in Clinical Trials of Anti-Rheumatic Drugs 3. The Elderly as the Main Group for Therapy with Anti-Rheumatic Drugs - Problems and Strategies 4. Changing Views on the Approach to Rehabilitation and Outcome Evaluation in Rheumatoid Arthritis, in the Light of Recent Advances in Cognitive Psychology 5. Mode of Action, Uses, and Side Effects of Anti-Inflammatory Drugs 6. Clinical Development of an NSAID Combined with a Prostaglandin E, Analogue 7. Azapropazone (AZP): New Therapeutic Indications for an Established Drug, Demonstration of Antineutrophil Effects in Various Animal Models and in Humans 8. Recent Advances in the Understanding of the Mode of Action of Glucorticoids 9. The Rheumaoid Arthritis Registry - An Update 10. Subreum (R) (OM-8980) and Rheumatoid Arthritis - A Novel Immunomodulating Drug from Natural Product Development 11. Clinical Trials of Oral Chrondroitin Suplhate in the Treatment of Osteoarthritis 12. Zileuon (ABT-077) A Novel 5-Lipoxygenase Inhibitor 13. Selective Monoclonal Antibodies for Therapy of Rheumatic Diseases 14. Dietary Polyunsaturdated Fatty Acids as Natural Therapeutic Rationales